Effect of palmitoylethanolamide on degeneration of a human-derived retinal pigment epithelial cell induced by all-trans retinal
Authors:
- 18 February 2023
- journal article
- research article
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 16 (2) , 191-200
Abstract
AIM: To study the effect of palmitoylethanolamide (PEA) on apoptosis of retinal pigment epithelial (RPE) cells induced by all-trans retinal (atRAL) and to explore the possible molecular mechanism. METHODS: CellTiter 96® Aqueous One Solution Cell Proliferation Assay (MTS) was used to detect the effect of PEA on human-derived retinal epithelial cells (ARPE-19) viability induced by atRAL. A Leica DMi8 inverted microscope was used to observe cell morphology. Reactive oxygen species (ROS) production was evaluated with 2’,7’-dichlorodihydrof-luorescein diacetate (H2DCFDA) staining and fluorescence microscopy. Expression of c-Jun N-terminal kinase (JNK), phosphorylated JNK (p-JNK), c-Jun, phosphorylated c-Jun (p-c-Jun), Bak, cleaved caspase-3, C/EBP homologous protein (CHOP), and binding (Bip) protein levels were tested by Western blot. Abca4-/-Rdh8-/- mice, mouse models of atRAL clearance defects which displays some symbolic characteristics of dry age-related macular degeneration (AMD) and Stargardt disease (STGD1). In the animal models, PEA was injected intraperitoneally. The full-field electroretinogram was used to detect visual function under scotopic conditions traced from mice. Optical coherence tomography showed reconstitution or thickening of the retinal pigment epithelium layer. Effect of PEA on fundus injury induced by light in Abca4-/-Rdh8-/- mice was observed by fundus photography. RESULTS: PEA ameliorated ARPE-19 cells apoptosis and inhibited ROS (including mitochondrial ROS) production induced by atRAL. PEA improved the retinal functional, prohibited both RPE and photoreceptor from death, ameliorates light-induced fundus impairment in Abca4-/-Rdh8-/- mice. In vitro and in vivo, PEA inhibited JNK, p-JNK, c-Jun, p-c-Jun, Bak, cleaved caspase-3, CHOP, and Bip protein levels induced by all-trans retinal in ARPE-19 cells. CONCLUSION: PEA has effect on treating RPE cells apoptosis in retinopathy caused by atRAL accumulation. PEA is a potential treatment strategy for dry AMD and STGD1. The molecular mechanism is affecting the ROS-JNK-CHOP signaling pathway partly.Keywords
This publication has 50 references indexed in Scilit:
- Mast cells, glia and neuroinflammation: partners in crime?Immunology, 2014
- Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common ColdInternational Journal of Inflammation, 2013
- Ocular Hypotensive Effect of Oral Palmitoyl-ethanolamide: A Clinical TrialInvestigative Ophthalmology & Visual Science, 2011
- Involvement of All-trans-retinal in Acute Light-induced Retinopathy of MiceJournal of Biological Chemistry, 2009
- Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic AgentsAnnual Review of Pharmacology and Toxicology, 2007
- Finding of endocannabinoids in human eye tissues: Implications for glaucomaBiochemical and Biophysical Research Communications, 2005
- Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell ProliferationMolecular Cell, 2004
- Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein KinasesScience, 2002
- Signal Transduction by the JNK Group of MAP KinasesCell, 2000
- Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine ReceptorsScience, 1996